Last reviewed · How we verify

Fibrinogen/thrombin-coated collagen patch — Competitive Intelligence Brief

Fibrinogen/thrombin-coated collagen patch (Fibrinogen/thrombin-coated collagen patch) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent / Surgical sealant. Area: Surgery / Hemostasis.

marketed Hemostatic agent / Surgical sealant Surgery / Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Fibrinogen/thrombin-coated collagen patch (Fibrinogen/thrombin-coated collagen patch) — Asan Medical Center. A collagen patch coated with fibrinogen and thrombin that promotes hemostasis by providing a scaffold for clot formation and delivering clotting factors directly to the wound site.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fibrinogen/thrombin-coated collagen patch TARGET Fibrinogen/thrombin-coated collagen patch Asan Medical Center marketed Hemostatic agent / Surgical sealant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent / Surgical sealant class)

  1. Asan Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fibrinogen/thrombin-coated collagen patch — Competitive Intelligence Brief. https://druglandscape.com/ci/fibrinogen-thrombin-coated-collagen-patch. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: